OCI Valuation

Is OIC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OIC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OIC (CHF10.38) is trading above our estimate of fair value (CHF9.86)

Significantly Below Fair Value: OIC is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for OIC?

Key metric: As OIC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OIC. This is calculated by dividing OIC's market cap by their current revenue.
What is OIC's PS Ratio?
PS Ratio1.3x
SalesUS$1.95b
Market CapUS$2.48b

Price to Sales Ratio vs Peers

How does OIC's PS Ratio compare to its peers?

The above table shows the PS ratio for OIC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.7x
CLN Clariant
0.9x4.3%CHF 3.6b
EMSN EMS-CHEMIE HOLDING
7.1x5.0%CHF 15.0b
VETN Vetropack Holding
0.6x3.1%CHF 531.3m
600486 Jiangsu Yangnong Chemical
2.1x18.0%CN¥21.5b
OIC OCI
1.3x3.6%CHF 2.4b

Price-To-Sales vs Peers: OIC is good value based on its Price-To-Sales Ratio (1.3x) compared to the peer average (2.7x).


Price to Sales Ratio vs Industry

How does OIC's PS Ratio compare vs other companies in the European Chemicals Industry?

27 CompaniesPrice / SalesEstimated GrowthMarket Cap
OIC 1.3xIndustry Avg. 1.0xNo. of Companies29PS01.22.43.64.86+
27 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OIC is expensive based on its Price-To-Sales Ratio (1.3x) compared to the European Chemicals industry average (1x).


Price to Sales Ratio vs Fair Ratio

What is OIC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OIC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.3x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate OIC's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OIC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
CHF 17.08
0%
46.1%CHF 32.83CHF 11.84n/a9
Nov ’25CHF 10.38
CHF 22.88
+120.3%
40.9%CHF 33.31CHF 11.60n/a9
Oct ’25n/a
CHF 30.01
0%
6.0%CHF 32.36CHF 27.45n/a9
Sep ’25n/a
CHF 29.67
0%
6.8%CHF 32.44CHF 24.84n/a12
Aug ’25n/a
CHF 29.22
0%
11.5%CHF 36.31CHF 22.93n/a12
Jul ’25n/a
CHF 29.16
0%
14.0%CHF 37.07CHF 21.41n/a13
Jun ’25n/a
CHF 29.70
0%
13.8%CHF 37.46CHF 21.82n/a13
May ’25n/a
CHF 29.53
0%
15.7%CHF 37.54CHF 21.74n/a12
Apr ’25n/a
CHF 29.03
0%
14.9%CHF 36.44CHF 22.40n/a12
Mar ’25n/a
CHF 29.00
0%
14.9%CHF 36.29CHF 22.31n/a12
Feb ’25n/a
CHF 26.63
0%
17.4%CHF 35.58CHF 18.84n/a12
Jan ’25n/a
CHF 25.00
0%
16.4%CHF 35.50CHF 18.80n/a12
Dec ’24n/a
CHF 25.56
0%
16.5%CHF 36.11CHF 19.10n/a12
Nov ’24n/a
CHF 29.10
0%
17.3%CHF 40.37CHF 22.95CHF 10.3812
Oct ’24n/a
CHF 30.12
0%
15.9%CHF 40.70CHF 24.02n/a12
Sep ’24n/a
CHF 29.70
0%
21.5%CHF 45.25CHF 23.19n/a13
Aug ’24CHF 25.10
CHF 28.45
+13.4%
21.0%CHF 44.55CHF 21.97n/a12
Jul ’24n/a
CHF 31.21
0%
21.0%CHF 45.16CHF 24.56n/a12
Jun ’24n/a
CHF 32.32
0%
19.9%CHF 45.47CHF 24.73n/a12
May ’24n/a
CHF 34.28
0%
17.1%CHF 44.78CHF 24.21n/a11
Apr ’24n/a
CHF 35.73
0%
13.9%CHF 45.83CHF 29.21n/a11
Mar ’24n/a
CHF 37.06
0%
11.8%CHF 43.79CHF 30.09n/a10
Feb ’24n/a
CHF 39.18
0%
8.8%CHF 45.74CHF 32.69n/a10
Jan ’24n/a
CHF 41.70
0%
9.3%CHF 47.49CHF 32.82n/a10
Dec ’23n/a
CHF 43.19
0%
9.0%CHF 49.05CHF 33.90n/a10
Nov ’23n/a
CHF 44.28
0%
9.5%CHF 51.42CHF 35.54n/a10

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies